James Barry - 01 May 2024 Form 3 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: EVP, President, LSG
Signature: /s/ James Barry
Issuer symbol: BIO
Transactions as of: 01 May 2024
Net transactions value: $0
Form type: 3
Filing time: 08 May 2024, 14:25:21 UTC
Next filing: 04 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BIO BIOB	Bio-Rad A Common Stock						31	01 May 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	BIO BIOB	Restricted Stock Units							01 May 2024	Bio-Rad A Common Stock	217	$0.000000	Direct	F1, F6
holding	BIO BIOB	Restricted Stock Units							01 May 2024	Bio-Rad A Common Stock	265	$0.000000	Direct	F2, F6
holding	BIO BIOB	Restricted Stock Units							01 May 2024	Bio-Rad A Common Stock	355	$0.000000	Direct	F3, F6
holding	BIO BIOB	Restricted Stock Units							01 May 2024	Bio-Rad A Common Stock	521	$0.000000	Direct	F4, F6
holding	BIO BIOB	Restricted Stock Units							01 May 2024	Bio-Rad A Common Stock	1,002	$0.000000	Direct	F5, F6
holding	BIO BIOB	Non-Qualified Stock Option (right to buy)							01 May 2024	Bio-Rad A Common Stock	1,179	$343.76	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On September 3, 2019, the reporting person was granted 1,083 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date.
F2	On September 2, 2020, the reporting person was granted 1,059 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F3	On September 1, 2021, the reporting person was granted 709 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F4	On September 1, 2022, the reporting person was granted 694 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F5	On September 1, 2023, the reporting person was granted 1,002 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F7	The option, representing a right to purchase a total of 1,179 shares, becomes exercisable in four equal annual installments beginning on March 8, 2025, which is the first anniversary of the date on which the option was granted.